Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
1 Year Return
+25.4%
3 Year Return
5 Year Return
10 Year Return
AUM
$1.27T
AUM Growth
-$18.6B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,591
New
Increased
Reduced
Closed

Top Buys

1 +$2.75B
2 +$2.14B
3
NVDA icon
NVIDIA
NVDA
+$1.64B
4
AMZN icon
Amazon
AMZN
+$1.53B
5
META icon
Meta Platforms (Facebook)
META
+$983M

Sector Composition

1 Technology 29.39%
2 Financials 14.52%
3 Healthcare 11.04%
4 Consumer Discretionary 10.43%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBHC
3901
The Brand House Collective
TBHC
$35.3M
$165K ﹤0.01%
130,660
-3,532
APWC icon
3902
Asia Pacific Wire & Cable
APWC
$40.4M
$164K ﹤0.01%
107,599
VVOS icon
3903
Vivos Therapeutics
VVOS
$23.4M
$163K ﹤0.01%
57,349
+12,522
AFCG
3904
AFC Gamma
AFCG
$77.7M
$163K ﹤0.01%
29,219
+4,467
NTIP icon
3905
Network-1 Technologies
NTIP
$35.6M
$163K ﹤0.01%
125,346
+11,896
RLYB icon
3906
Rallybio
RLYB
$21.3M
$162K ﹤0.01%
247,552
-275
PLMK
3907
Plum Acquisition Corp IV
PLMK
$250M
$161K ﹤0.01%
+16,059
PIII icon
3908
P3 Health Partners
PIII
$30.1M
$161K ﹤0.01%
19,608
+647
ENZ
3909
DELISTED
Enzo Biochem, Inc.
ENZ
$160K ﹤0.01%
431,042
+63,949
FCUV icon
3910
Focus Universal
FCUV
$25.4M
$159K ﹤0.01%
38,231
+10,280
GTN.A icon
3911
Gray Media Inc
GTN.A
$1.06B
$159K ﹤0.01%
20,141
+2,627
FATBB
3912
FAT Brands
FATBB
$45.5M
$159K ﹤0.01%
60,053
-12,927
TOYO
3913
TOYO Co
TOYO
$249M
$159K ﹤0.01%
53,111
-6,861
RDCM icon
3914
Radcom
RDCM
$228M
$156K ﹤0.01%
13,668
NEPH icon
3915
Nephros
NEPH
$57.2M
$155K ﹤0.01%
90,289
+5,439
CGTX icon
3916
Cognition Therapeutics
CGTX
$161M
$155K ﹤0.01%
368,961
+16,613
ARMP icon
3917
Armata Pharmaceuticals
ARMP
$115M
$155K ﹤0.01%
105,837
-952
INTZ
3918
Intrusion
INTZ
$34.6M
$154K ﹤0.01%
137,690
+69,028
USAR
3919
USA Rare Earth Inc
USAR
$3.71B
$153K ﹤0.01%
25,745
INTS icon
3920
Intensity Therapeutics
INTS
$14.9M
$153K ﹤0.01%
77,482
+13,133
CREX icon
3921
Creative Realities
CREX
$28.8M
$152K ﹤0.01%
77,696
+36
MYSE
3922
Myseum Inc
MYSE
$12M
$151K ﹤0.01%
39,214
+14,529
IMNN icon
3923
Imunon
IMNN
$12.8M
$151K ﹤0.01%
10,997
+302
NAII icon
3924
Natural Alternatives International
NAII
$16.4M
$150K ﹤0.01%
43,633
-1,429
PTN
3925
DELISTED
Palatin Technologies
PTN
$150K ﹤0.01%
257,532
+66,978